Project Grant D43TW009522

FEND-TB Project Grant Summary Rutgers, The State University of New Jersey (RBHS-School of Nursing) received a $3.09 million Project Grant from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), awarded September 10, 2025, with a completion date of August 31, 2030. The grant supports the development and evaluation of tuberculosis (TB) diagnostic tools and drug susceptibility tests (DSTs) through a...

FAST-TB Project Grant Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded $3.5 million through the Allergy and Infectious Diseases Research program (CFDA 93.855) to the University of California, San Francisco on June 8, 2026, to support the Facilitating Accelerated Science and Translation for TB Regimen Development (FAST-TB) initiative through May 31, 2031. This project grant delivers shared infrastructure and durable resources designed to accelerate the evaluation,...

Federal Cooperative Agreement Summary RE-EVALUATING THE DURATION IN CHILDREN OF TB TREATMENT (REDUCE TB): A PHASE 2 DURATION RANDOMIZED TRIAL The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $2.9 million Cooperative Agreement to the University of Wisconsin–Madison on September 19, 2025, to conduct a Phase 2 randomized clinical trial evaluating optimal treatment duration for drug-susceptible tuberculosis in children. The REDUCE TB trial will randomize pediatric...

Federal Grant Award Summary The Medical Research Council Unit The Gambia at the London School of Hygiene & Tropical Medicine received a $273,436 Project Grant award dated September 16, 2025, from the Fogarty International Center under the International Research and Research Training program (CFDA 93.989). The project, led by Principal Investigator Dr. Esin Nkereuwem, investigates the long-term sequelae of pulmonary tuberculosis in Gambian children and adolescents through September 2030. This...

Federal Grant Award Summary Mahidol University received a $151,200 Project Grant from the John E. Fogarty International Center (FIC) under the International Research and Research Training program (CFDA 93.989), awarded September 16, 2025, with performance through August 31, 2030. The award supports research conducted in Thailand to characterize the cyclic-di-AMP (c-di-AMP) pathway in Clostridioides difficile as a novel drug target for addressing antimicrobial resistance (AMR). The research...

Federal Project Grant Award Summary Boston Medical Center Corporation received a $1,271,538 Project Grant awarded June 18, 2026, from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855). The grant supports the TACTIC (Tuberculosis Active Case Tracking Via Interpersonal Connections) study, which will be conducted in Kampala, Uganda through May 31, 2031. The project delivers research services to evaluate...

Federal Project Grant Award Summary Hanoi Medical University received a $166,535 Project Grant from the Fogarty International Center (FIC) under the International Research and Research Training program (CFDA 93.989) for the period of March 1, 2026 through February 29, 2028. The award supports the adaptation and pilot testing of Project YES+, an evidence-based intervention combining peer mentoring and group-based mental health services, to address depression, anxiety, and HIV-related stigma among...

Federal Project Grant Award Summary The Fogarty International Center (FIC) of the National Institutes of Health awarded $1.26 million to the University of California, Los Angeles on August 20, 2025, under the International Research and Research Training program (CFDA 93.989) to support research addressing HIV treatment engagement disparities in Indonesia. The award funds a three-year project (completion date: July 31, 2028) to culturally adapt an evidence-based intervention designed to reduce...

Federal Grant Award Summary Boston Medical Center Corporation received a $795,622 Project Grant from the National Institute of Allergy and Infectious Diseases under the Allergy and Infectious Diseases Research program (CFDA 93.855), awarded May 1, 2026, with completion targeted for April 30, 2031. The MYTHIC (Mycobacterium tuberculosis Impact on HIV Reservoir Clearance) study will examine how tuberculosis (TB) disease affects HIV-1 latent reservoirs and the efficacy of cure-directed...

The University of Maryland, Baltimore received a $248,306 Project Grant from the Fogarty International Center under the International Research and Research Training program (CFDA 93.989) on August 1, 2025, with a completion date of May 31, 2030. The Strengthening Surgical Scientists Capacity for NCD-Lifespan Research (SSSCAR) Program delivers multidisciplinary graduate training initiatives designed to build research and clinical capacity among West African College of Surgeons (WACS) trainees...